Lancet Respiratory Medicine 期刊简介

Lancet Respiratory Medicine
英文简介:

The Lancet Respiratory Medicine delivers comprehensive, clinically-focused coverage on all areas of respiratory medicine and critical care, including but not limited to: COPD, asthma, cystic fibrosis, IPF, pneumonia, influenza, tuberculosis, sarcoidosis, pulmonary hypertension, sleep medicine, respiratory infections, pulmonary vascular disease, lung cancer, tobacco control, thoracic and reconstructive surgery, mesothelioma, and palliative medicine. Continuing in The Lancet's tradition of publishing high-impact content that influences medical practice, each monthly issue of The Lancet Respiratory Medicine contains Original Research, Reviews, Personal Views, Comments, and News.

The Lancet Respiratory Medicine is stringently edited and peer-reviewed to ensure the scientific merit and clinical relevance of its diverse content. Original Research is fast-tracked to publication within 8 weeks of submission (on average) and published Online First on www.thelancet.com before appearing in print.

Now indexed in PubMed, Journal Citation Reports®, and Scopus, the journal accepts submissions of Original Research, Reviews, Personal Views, and Comments. Visit http://ees.elsevier.com/thelancetrm to learn more about our editorial scope and aims and to submit your manuscript.

Gold or Green Open Access is available for research supported by selected funding agencies with whom Elsevier has an agreement. The journal is also freely available to readers in low-to-middle-income countries via the HINARI programme or via IP access at www.thelancet.com.

To find out more about The Lancet Respiratory Medicine, visit www.thelancet.com/respiratory.

中文简介:(来自Google、百度翻译)

柳叶刀呼吸医学提供全面,临床重点覆盖呼吸医学和重症监护的所有领域,包括但不限于: COPD,哮喘,囊性纤维化,IPF,肺炎,流感,结核病,结节病,肺动脉高压,睡眠医学,呼吸道感染,肺血管疾病,肺癌,烟草控制,胸腔和重建手术,间皮瘤和姑息医学。延续《柳叶刀》出版影响医疗实践的高影响力内容的传统,《柳叶刀呼吸医学》每月发行一次包含原创研究,评论,个人观点,评论,和新闻。
柳叶刀呼吸医学经过严格编辑和同行评审,以确保其多样化内容的科学价值和临床相关性。原创研究在提交后的8周内 (平均) 快速发布,并首先在www.thelancet.com上在线发布,然后出版。
现已在PubMed、Journal Citation Reports® 和Scopus中获得索引,该期刊接受原创研究、评论、个人观点、和评论。请访问http://ees.elsevier.com/thelancetrm,以了解有关我们的编辑范围和目标的更多信息,并提交您的手稿。
Gold或Green Open Access可用于由Elsevier与之达成协议的选定资助机构支持的研究。该杂志也可以通过HINARI计划或通过www.thelancet.com上的IP访问向中低收入国家的读者免费提供。
要了解有关《柳叶刀》呼吸医学的更多信息,请访问www.thelancet.com/respiratory。

期刊ISSN
2213-2600
影响指数
30.393
最新CiteScore值
43.70 查看CiteScore评价数据
最新自引率
1.80%
官方指定润色网址
https://www.deeredit.com/?type=ss1
投稿语言要求

Improve the quality of the paper, eliminate grammar and spelling errors, increase readability, ensure accurate communication of viewpoints, enhance academic reputation, and increase the chances of the paper being accepted.

建议点击这个网址:https://www.deeredit.com/?type=ss2,资深审稿专家为您评估稿件质量,提供针对性改进建议,最终可助您极大提升目标期刊录用率

期刊官方网址

hot

https://www.peipusci.com/?type=9
杂志社征稿网址

hot

https://www.peipusci.com/?type=10
通讯地址
THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND, OXON, OX5 1GB
偏重的研究方向(学科)
RESPIRATORY SYSTEM-RESPIRATORY SYSTEM
出版周期
出版年份
0
出版国家/地区
ENGLAND
是否OA
No
SCI期刊coverage
Science Citation Index Expanded(科学引文索引扩展)
NCBI查询
PubMed Central (PMC)链接 全文检索(pubmed central)
Lancet Respiratory Medicine 期刊中科院JCR 评价数据
最新中科院JCR分区
大类(学科)
小类(学科)
综述期刊
医学
CRITICAL CARE MEDICINE(危重病医学)1区 RESPIRATORY SYSTEM(呼吸系统)1区
最新的影响因子
30.393
最新公布的期刊年发文量
年度总发文量 研究类文章占比
82 86.59%
总被引频次 79
影响因子趋势图
近年的影响因子趋势图(整体平稳趋势)

2022年预警名单预测最新

Lancet Respiratory Medicine 期刊CiteScore评价数据
最新CiteScore值
43.70
年文章数 82
SJR
9.030
SNIP
8.896
CiteScore排名
序号 类别(学科) 排名 百分位
1 Medicine Pulmonary and Respiratory Medicine #1/133
CiteScore趋势图
CiteScore趋势图
Lancet Respiratory Medicine 投稿经验(由下方点评分析获得,0人参与,1824人阅读)
投稿录用比例: 0.030470
审稿速度: 暂无
分享者 点评内容
没有更多了~
Copyright © 2014-2019 晟斯医学 All Rights Reserved. 备案号:苏ICP备11037034号-5 版权所有:南京孜文信息咨询有限公司